Cyntegrity | Data Science for Clinical Trials
Follow Us on LinkedIn

Leadership Roundtable

4 September 2025 @ Microsoft Messeturm Franktfurt, Germany. "Implementing QbD with AI" - a complimentary forum for 40 senior delegates. Request an invitation while seats last.

Thank you—your registration is now on record. You will receive a personal confirmation email shortly, followed by a final participation notice within three weeks, and no later than 11 August.

Accelerate Trials, Stay Inspection-Ready

Boards, regulators, and patients all expect faster studies that never compromise on quality. On 4 September, join Microsoft and Cyntegrity for a high-impact roundtable on how AI-powered Quality-by-Design (QbD) and Risk-Based Quality Management (RBQM) deliver inspection-ready trials without blowing the budget.

Key Take-aways

Trust

Metric framework for Responsible AI in GxP.

Security

Data protection playbook to satisfy GDPR & ICH E6(R3).

ROI

Proven time-to-value from predictive risk signals.

Preliminary Agenda

Preliminary Agenda Snapshot

12:00 | Arrival & Networking Lunch

12:30 | Opening - "Why AI-Driven QbD Has Reached the Boardroom"
12:40 | Keynote 1 - "Responsible AI in Practice: Trust, Security, & ROI for Clinical Trials"

13:25 | Espresso & Peer Exchange

13:40 | Keynote 2 - "AI-Enabled QbD in Practice: Cycle-Time, Cost-of-Quality, and Inspection Readiness"
14:25 | Case Study - "From Manual Checks to Predictive Quality: How a Sponsor Cut Database-Lock Time by 30% with AI-Augmented RBQM."
14:55 | Executive Panel - "Trust, Validation & Reproducibility: De-Risking AI-Adoption"

15:40 | Interactive Q&A & Next Steps
16:10 | Closing Reception & Skyline Networking (until 17:00)
AI Futurescape

Speaker Sneak Peek

First speakers announced; a growing line-up of leaders driving inspection-ready AI.

"Leaders who build inspection-ready trials don't gamble on quality - they engineer it."

Artem Andrianov, PhD · CEO – Cyntegrity • AI-Augmented RBQM

Artem Andrianov, PhD

CEO and founder of Cyntegrity,
architect of AI-augmented RBQM
delivering faster, inspection-ready
trials worldwide.
Aurelie Dequelson, Head of Risk Surveillance at Novartis

Aurelie Dequelson

Head of Risk Surveillance, Aurelie leads
risk-based quality management strategy
and drives its adoption across Novartis' development portfolio.
Ida Holme, MD - Head of RBQM at Novo Nordisk

Ida Holme, MD

Head of RBQM, Ida brings experience
from previous leadership roles at
Novo Nordisk and holds a
Doctor of Medicine degree.
Johann Proeve, PhD at Cyntegrity

Johann Proeve, PhD

Former Bayer data-management
leader, now Cyntegrity CSO,
advancing QbD standards
through predictive analytics.
Shehnaz Vakharia, MRQA - VP, APAC at ADAMAS

Shehnaz Vakharia, MRQA

VP, APAC at ADAMAS Consulting,
Shehnaz is a seasoned GxP auditor
who guides sponsors in inspection-ready,
risk-based quality systems.
Andrew Warrington · Industry CTO, Health – Microsoft • Operationalising Responsible AI

Andrew Warrington

Microsoft Senior Industry Advisor
guiding responsible AI adoption
for secure, compliant, cloud-driven
clinical research.
Event Details

Event Details


Secure your complimentary seat - only 40 senior places available. RSVP by 15 August, and please cancel promptly if your plans change.

For any questions or additional details please reach out to Tamara Beck, our MyRBQM Academy Operations Manager, at:

Event Dates

Date

Thursday, September 4, 2025

Event Time

Time

12:00 - 17:00 CEST

Event Format

Format

In-person: Frankfurt, Germany

Event Format

Cost

Complimentary (incl. lunch, cocktail)

Who Should Attend

VPs / Directors in Clinical Ops, Quality, Digital Transformation & Data Science who plan to embed Responsible AI in study oversight within 12 months.

AI-Augmented RBQM Solutions

© 2025 Cyntegrity - All Rights Reserved

Cyntegrity | Data Science for Clinical Trials